Second wave of recruitment campaign gets underway today
23rd October 2015 - Pfizer today announces approximately 130 jobs across three manufacturing sites in Ireland including Grange Castle in Dublin and Little Island and Ringaskiddy in Cork and a recruitment drive is underway. Pfizer employs approximately 3,200 people at six sites in Ireland across manufacturing, shared services, R&D, treasury and commercial operations and has invested $7 billion in operations in Ireland since 1969. Pfizer’s operations in Ireland including recent investments of $330million are supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland. Information for applicants about the roles and deadlines for application are available on www.pfizercareers.com and www.pfizer.ie
Welcoming the announcement Minister for Jobs, Enterprise and Innovation Richard Bruton said: "A key part of our Action Plan for Jobs has been attracting companies into Ireland through the IDA’s work and ensuring that every region in the country benefits from job creation. Pfizer with six sites in Ireland has been in Ireland since 1969 and has expanded with the support of my Department through IDA. I welcome Pfizer’s announcement today that it is recruiting in Dublin and Cork and I wish them every success for the future."
Dr Paul Duffy, Vice President, Pfizer said: "Pharmaceutical manufacturing in Ireland continues to perform well contributing strongly to exports and economic growth, and providing good careers and jobs. Students should give strong consideration to studying STEM* subjects all of which provide a route into pharmaceutical manufacturing. This provides a good career path but also provides a chance to be part of delivering innovative medicines to patients to help treat devastating diseases," he said. "Pfizer is one of Ireland’s leading employers and economic contributors. Our sites in Ireland manufacture some of Pfizer’s leading and newest medicines for export globally."
Grange Castle based in West Dublin is looking to recruit across multiple functions including process scientists; process/equipment engineers; automation engineers; operations specialists; process technicians; quality analysts and project managers. Advertising gets underway in print media and on radio for the Grange Castle jobs today.
Pfizer Grange Castle is one of Pfizer’s leading biologic manufacturing sites globally with state of the art technologies. The site manufactures highly specialized and complex medicines and vaccines involving large scale mammalian cell culture; protein purification; aseptic/ sterile manufacturing and vaccines conjugation. The site successfully secured $300 million in investment in recent years to expand production capacity.
Mr. Julien Deneve, Site Lead, Grange Castle said: "Pfizer Grange Castle is delighted to announce we are recruiting 90 very good roles. We are looking for candidates to join our world class colleagues in this innovative, exciting and growing organisation. The Pfizer Grange Castle site is a leading world class facility in the Pfizer global network and is one of the largest integrated biotechnology plants in the world. The type of work conducted on the site is highly specialised and requires top level people across the fields of science, engineering and biotechnology."
The Ringaskiddy and Little Island sites also have recruitment activity underway to fill over 40 positions in Cork. These roles include process operators, mechanical & electrical/instrumentation craft, process engineers, process chemists, and quality control analysts. Pfizer Ringaskiddy recently secured $30 million investment to develop specialist new capability to manufacture some of Pfizer’s newest cancer medicines and other future pipeline medicines. The investment enabled the introduction of new innovative technologies which required more specialised R&D skills.
Seamus Fives, Site Lead Ringaskiddy and Little Island said: "We are delighted to announce the news Pfizer is hiring and we look forward to expanding our team. These new positions are key roles within the organisation and play an important function in the manufacturing and delivery of medicines to patients worldwide. The sites in Cork play a key role in scaling up manufacturing of Pfizer’s newest medicines but also in manufacturing some of Pfizer’s older medicines which remain important medicines for patients."
Pfizer is prioritizing its research and development efforts in areas where we can make the biggest difference to health and social care burdens: immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain, and vaccines. Pfizer’s pipeline currently comprises more than 80 innovative therapies, including potentially first-in-class vaccines for two deadly hospital-acquired infections, new antibodies for lupus and high cholesterol and the next-generation of targeted therapies for cancer. In oncology, we continue to build a strong portfolio of potential cancer therapies and we are also advancing our pipeline assets in rare diseases and personalised medicines. Specialized efforts in rare diseases also illustrate our dedication to developing and delivering innovative medicines and vaccines that will benefit patients around the world.
*STEM – science, technology, engineering, maths
Published: 23rd October 2015.